ACADIA Pharmaceuticals IncNASDAQ:ACAD
- LAST PRICE17.9300
- TODAY'S CHANGE (%)-0.3400 (-1.8610%)
- Bid / Lots17.8000/ 1
- Ask / Lots18.6600/ 1
- Open / Previous Close18.1600 / 18.2700
- Day Range
- 52 Week Range
- Volume989,654
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACAD |
|---|---|---|
| 09:32 ET | 11985 | 18.17 |
| 09:33 ET | 1650 | 18.185 |
| 09:35 ET | 770 | 18.24 |
| 09:37 ET | 1000 | 18.2394 |
| 09:39 ET | 1347 | 18.265 |
| 09:42 ET | 3389 | 18.27 |
| 09:44 ET | 5750 | 18.3 |
| 09:46 ET | 800 | 18.266923 |
| 09:48 ET | 4408 | 18.33 |
| 09:50 ET | 1901 | 18.34 |
| 09:51 ET | 1900 | 18.35 |
| 09:53 ET | 1788 | 18.39 |
| 09:55 ET | 300 | 18.345 |
| 09:57 ET | 200 | 18.35 |
| 10:00 ET | 539 | 18.32 |
| 10:02 ET | 1550 | 18.39 |
| 10:04 ET | 10891 | 18.35 |
| 10:06 ET | 330 | 18.335 |
| 10:08 ET | 1172 | 18.32 |
| 10:09 ET | 10992 | 18.35 |
| 10:11 ET | 640 | 18.37 |
| 10:13 ET | 403 | 18.36 |
| 10:15 ET | 1756 | 18.35 |
| 10:18 ET | 2200 | 18.3729 |
| 10:20 ET | 1167 | 18.36 |
| 10:22 ET | 4061 | 18.37 |
| 10:24 ET | 1700 | 18.34 |
| 10:26 ET | 1250 | 18.32 |
| 10:27 ET | 4800 | 18.34 |
| 10:29 ET | 700 | 18.3768 |
| 10:31 ET | 100 | 18.37 |
| 10:33 ET | 1289 | 18.33 |
| 10:36 ET | 708 | 18.35 |
| 10:38 ET | 3113 | 18.31 |
| 10:40 ET | 6081 | 18.29 |
| 10:42 ET | 4540 | 18.3 |
| 10:44 ET | 900 | 18.3 |
| 10:45 ET | 1272 | 18.3 |
| 10:47 ET | 1623 | 18.34 |
| 10:49 ET | 1000 | 18.33 |
| 10:51 ET | 200 | 18.325 |
| 10:54 ET | 500 | 18.31 |
| 10:56 ET | 500 | 18.32 |
| 10:58 ET | 1811 | 18.32 |
| 11:00 ET | 8400 | 18.3 |
| 11:02 ET | 2546 | 18.275 |
| 11:03 ET | 11407 | 18.31 |
| 11:05 ET | 900 | 18.315 |
| 11:07 ET | 300 | 18.315 |
| 11:09 ET | 100 | 18.3 |
| 11:12 ET | 1105 | 18.3 |
| 11:14 ET | 7353 | 18.27 |
| 11:16 ET | 2093 | 18.25 |
| 11:18 ET | 111 | 18.25 |
| 11:20 ET | 1573 | 18.2529 |
| 11:21 ET | 1941 | 18.27 |
| 11:23 ET | 2126 | 18.22 |
| 11:25 ET | 200 | 18.22 |
| 11:27 ET | 2840 | 18.25 |
| 11:30 ET | 500 | 18.225 |
| 11:32 ET | 516 | 18.25 |
| 11:34 ET | 600 | 18.25 |
| 11:36 ET | 500 | 18.26 |
| 11:38 ET | 400 | 18.27 |
| 11:39 ET | 1387 | 18.24 |
| 11:41 ET | 300 | 18.24 |
| 11:43 ET | 684 | 18.21 |
| 11:48 ET | 1295 | 18.19 |
| 11:50 ET | 1036 | 18.16 |
| 11:52 ET | 560 | 18.125 |
| 11:54 ET | 2409 | 18.13 |
| 11:56 ET | 414 | 18.125 |
| 11:57 ET | 421 | 18.115 |
| 11:59 ET | 689 | 18.11 |
| 12:01 ET | 400 | 18.11 |
| 12:03 ET | 1671 | 18.08 |
| 12:06 ET | 1200 | 18.09 |
| 12:08 ET | 900 | 18.11 |
| 12:10 ET | 200 | 18.1059 |
| 12:12 ET | 800 | 18.14 |
| 12:14 ET | 1270 | 18.11 |
| 12:15 ET | 902 | 18.1 |
| 12:17 ET | 6082 | 18.05 |
| 12:19 ET | 1690 | 18.025 |
| 12:21 ET | 928 | 18.015 |
| 12:24 ET | 1752 | 18.015 |
| 12:26 ET | 3400 | 17.995 |
| 12:28 ET | 1917 | 18 |
| 12:30 ET | 4527 | 18.03 |
| 12:32 ET | 1185 | 18.04 |
| 12:33 ET | 291 | 18.06 |
| 12:35 ET | 1806 | 18.05 |
| 12:37 ET | 600 | 18.04 |
| 12:39 ET | 665 | 18.04 |
| 12:42 ET | 300 | 18.04 |
| 12:44 ET | 3104 | 18.07 |
| 12:46 ET | 2604 | 18.08 |
| 12:48 ET | 650 | 18.08 |
| 12:50 ET | 1584 | 18.082 |
| 12:51 ET | 1000 | 18.08 |
| 12:53 ET | 1523 | 18.08 |
| 12:55 ET | 400 | 18.09 |
| 12:57 ET | 2856 | 18.05 |
| 01:00 ET | 1611 | 17.9832 |
| 01:02 ET | 606 | 17.96 |
| 01:04 ET | 1569 | 17.99 |
| 01:06 ET | 730 | 18.0078 |
| 01:08 ET | 700 | 18 |
| 01:09 ET | 200 | 17.98 |
| 01:11 ET | 581 | 17.975 |
| 01:13 ET | 2106 | 17.97 |
| 01:15 ET | 2562 | 17.98 |
| 01:18 ET | 2078 | 17.96 |
| 01:20 ET | 580 | 17.96 |
| 01:22 ET | 900 | 17.97 |
| 01:24 ET | 2051 | 17.95 |
| 01:27 ET | 700 | 17.96 |
| 01:29 ET | 665 | 17.965 |
| 01:31 ET | 1159 | 17.975 |
| 01:33 ET | 4834 | 17.95 |
| 01:36 ET | 432 | 17.945 |
| 01:38 ET | 1874 | 17.95 |
| 01:40 ET | 1976 | 17.95 |
| 01:42 ET | 100 | 17.95 |
| 01:44 ET | 1321 | 17.94 |
| 01:45 ET | 1195 | 17.96 |
| 01:47 ET | 886 | 17.99 |
| 01:49 ET | 100 | 18.02 |
| 01:51 ET | 600 | 18.01 |
| 01:54 ET | 2000 | 18.03 |
| 01:56 ET | 1396 | 18.01 |
| 01:58 ET | 742 | 18.03 |
| 02:00 ET | 1100 | 18 |
| 02:02 ET | 300 | 18 |
| 02:03 ET | 3100 | 18.02 |
| 02:05 ET | 2000 | 17.99 |
| 02:07 ET | 403 | 17.975 |
| 02:09 ET | 24145 | 17.99 |
| 02:12 ET | 1715 | 18.02 |
| 02:14 ET | 200 | 18.02 |
| 02:16 ET | 400 | 18.01 |
| 02:18 ET | 1000 | 18 |
| 02:20 ET | 2354 | 18.03 |
| 02:21 ET | 2895 | 18.04 |
| 02:23 ET | 1075 | 18.08 |
| 02:25 ET | 973 | 18.1 |
| 02:27 ET | 600 | 18.085 |
| 02:30 ET | 1884 | 18.09 |
| 02:32 ET | 1501 | 18.085 |
| 02:34 ET | 500 | 18.11 |
| 02:36 ET | 105 | 18.1 |
| 02:38 ET | 400 | 18.11 |
| 02:39 ET | 853 | 18.12 |
| 02:41 ET | 1100 | 18.105 |
| 02:43 ET | 600 | 18.11 |
| 02:45 ET | 2695 | 18.091 |
| 02:48 ET | 2276 | 18.095 |
| 02:52 ET | 779 | 18.1 |
| 02:54 ET | 1010 | 18.11 |
| 02:56 ET | 1999 | 18.075 |
| 02:57 ET | 4000 | 18.08 |
| 02:59 ET | 1744 | 18.09 |
| 03:01 ET | 4700 | 18.15 |
| 03:03 ET | 1897 | 18.13 |
| 03:06 ET | 2505 | 18.115 |
| 03:08 ET | 2922 | 18.1183 |
| 03:10 ET | 2239 | 18.11 |
| 03:12 ET | 1000 | 18.115 |
| 03:14 ET | 600 | 18.11 |
| 03:15 ET | 4195 | 18.119 |
| 03:17 ET | 8231 | 18.1 |
| 03:19 ET | 2000 | 18.09 |
| 03:21 ET | 2422 | 18.03 |
| 03:24 ET | 300 | 18.03 |
| 03:26 ET | 1553 | 18.03 |
| 03:28 ET | 1041 | 17.979 |
| 03:30 ET | 2662 | 17.99 |
| 03:32 ET | 1200 | 17.96 |
| 03:33 ET | 4107 | 17.93 |
| 03:35 ET | 2300 | 17.91 |
| 03:37 ET | 4311 | 17.899 |
| 03:39 ET | 4521 | 17.865 |
| 03:42 ET | 2125 | 17.87 |
| 03:44 ET | 2188 | 17.875 |
| 03:46 ET | 12584 | 17.91 |
| 03:48 ET | 705 | 17.94 |
| 03:50 ET | 4863 | 17.92 |
| 03:51 ET | 5809 | 17.95 |
| 03:53 ET | 7087 | 17.945 |
| 03:55 ET | 6808 | 17.96 |
| 03:57 ET | 11511 | 17.87 |
| 04:00 ET | 289743 | 17.93 |
Nov 7, 2024
DJ ACADIA Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham, from 8:12AM ET on Thursday Nov 07, 2024 by Dow Jones
8:12AM ET on Thursday Nov 07, 2024 by Dow JonesDJ ACADIA Pharmaceuticals Price Target Maintained With a $27.00/Share by HC Wainwright & Co., from 7:48AM ET on Thursday Nov 07, 2024 by Dow Jones
7:48AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
DJ Acadia Pharmaceuticals to Sell Rare Pediatric Disease Priority Review Voucher, from 5:19PM ET on Tuesday Nov 05, 2024 by Dow Jones
5:19PM ET on Tuesday Nov 05, 2024 by Dow Jones*DJ ACADIA Pharmaceuticals Is Required to Pay Neuren One-Third of the Net Proceeds >ACAD, from 4:07PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:07PM ET on Tuesday Nov 05, 2024 by Dow JonesAcadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ACADIA Pharmaceuticals Inc | 3.0B | 23.1x | --- |
Azenta Inc | 2.2B | -16.3x | --- |
Amicus Therapeutics Inc | 3.2B | -30.3x | --- |
Catalyst Pharmaceuticals Inc | 2.8B | 19.7x | --- |
Veracyte Inc | 3.0B | -264.7x | --- |
Beam Therapeutics Inc | 2.5B | -16.2x | --- |
Company Information
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Contact Information
- Headquarters
- 12830 El Camino Real, Suite 400SAN DIEGO, CA, United States 92130
- Phone
- 858-558-2871
- Fax
- 858-558-2872
Executives
- Independent Chairman of the Board
- Stephen Biggar
- Chief Executive Officer, Director
- Catherine Owen Adams
- Chief Financial Officer, Executive Vice President
- Mark Schneyer
- Chief Operating Officer, Executive Vice President, Head of Commercial
- Brendan Teehan
- Executive Vice President, Company Secretary and Chief Legal Officer
- Jennifer Rhodes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
|---|---|
Revenue (TTM) | $929.2M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.43 |
EPS | $0.78 |
Book Value | $2.62 |
P/E Ratio | 23.1x |
Price/Sales (TTM) | 3.3 |
Price/Cash Flow (TTM) | 21.5x |
Operating Margin | 12.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
